Spectral AI (MDAI) EBITDA Margin (2022 - 2026)

Spectral AI (MDAI) reported EBITDA Margin of 85.74% for Q1 2026, down 12919.0% on a YoY basis from N/an in Q1 2025, and down 432.71% quarter-over-quarter from 25.77% in Q4 2025.

Spectral AI (MDAI) EBITDA Margin (2022 - 2026) Analysis & Trends

Spectral AI has reported EBITDA Margin for 5 years, with the latest figure at 85.74% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 12919.0% year-over-year to 85.74%; the trailing twelve-month figure through Mar 2026 stood at 81.91% (down 5171.0% YoY), and the FY2025 full-year result was 38.34%, up 1293.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 85.74%, down from 25.77% in the prior quarter.
  • The five-year high for EBITDA Margin was 43.45% in Q1 2025, with the low at 309.07% in Q3 2023.
  • Historically, EBITDA Margin has averaged 68.41% across 5 years, with a median of 66.84% in 2023.
  • Annual changes were most pronounced in 2023 — EBITDA Margin slumped 30550 bps — and 2024, when it soared 29085 bps.
  • Spectral AI's EBITDA Margin stood at 29.02% in 2022, then slumped by 130 bps to 66.84% in 2023, then slumped by 50 bps to 100.04% in 2024, then soared by 126 bps to 25.77% in 2025, then plunged by 433 bps to 85.74% in 2026.
  • The last three EBITDA Margin figures came in at 85.74% (Q1 2026), 25.77% (Q4 2025), and 94.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Spectral AI 57.48 Mn 45.82 Mn 2.03 Mn -85.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 -85.74%
Dec 31, 2025 25.77%
Sep 30, 2025 -94.01%
Jun 30, 2025 -156.68%
Mar 31, 2025 43.45%
Dec 31, 2024 -100.04%
Sep 30, 2024 -18.22%
Jun 30, 2024 -38.30%
Mar 31, 2024 -50.70%
Dec 31, 2023 -66.84%
Sep 30, 2023 -309.07%
Jun 30, 2023 -72.17%
Mar 31, 2023 -71.05%
Dec 31, 2022 -29.02%
Sep 30, 2022 -3.57%